A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9–11 year-old girls and boys – clinical protocol

Yi Zeng (Creator)
Anna Barbara Moscicki (Contributor)
Vikrant V. Sahasrabuddhe (Contributor)
Francisco Garcia (Pima County Health Department) (Creator)
Heide Woo (Creator)
Chiu-Hsieh Hsu (Contributor)
Eva Szabo (Creator)
Eileen DImond (Contributor)
Susan Vanzzini (Creator)
Angelica Mondragon (Creator)
Valerie D. Butler (Creator)
Hillary DeRose (Creator)
H.-H. Sherry Chow (Contributor)

Dataset

1 Article

1 results

Filter

2019
A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - Clinical protocol
Zeng, Y., Moscicki, A. B., Sahasrabuddhe, V. V., Garcia, F. A., Woo, H., Hsu, C. H., Szabo, E., DImond, E., Vanzzini, S., Mondragon, A., Butler, V., DeRose, H. & Chow, H. H. S., Apr 1 2019, In: BMC Cancer. 19, 1, 290.
Research output: Contribution to journal › Article › peer-review

Open Access
6 Scopus citations